Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis.

Saved in:
Bibliographic Details
Title: Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis.
Authors: Riedl MA; Division of Allergy and Immunology, University of California San Diego, La Jolla, Calif., Bernstein JA; Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Bernstein Clinical Research Center, LLC, Cincinnati, Ohio., Jacobs JS; Allergy and Asthma Clinical Research, Inc., Walnut Creek, Calif., Craig T; Department of Medicine, Pediatrics, and Biomedical Sciences, Penn State Health Allergy, Asthma, and Immunology, Hershey, Pa; Department of General Internal Medicine, Vinmec International Hospital, Times City, Hanoi, Vietnam., Banerji A; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., Perego F; Department of Internal Medicine, Istituto di Ricovero e Cura a Carattere Scientifico, Istituti Clinici Scientifici Maugeri, Milan, Italy., Lumry WR; Asthma and Allergy Research Associates, Dallas, Texas., Wedner HJ; Division of Allergy and Immunology, Washington University, St Louis, Mo., Gierer S; Division of Allergy, Clinical Immunology, and Rheumatology, University of Kansas Medical Center, Kansas City, Kan., Manning ME; Medical Research of Arizona, Scottsdale, Ariz., Bordone L; Ionis, Carlsbad, Calif., Treadwell S; Ionis, Carlsbad, Calif., Lin T; Ionis, Carlsbad, Calif., Newman KB; Ionis, Carlsbad, Calif., Yarlas A; Ionis, Carlsbad, Calif., Cohn DM; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: d.m.cohn@amsterdamumc.nl.
Source: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2025 Sep; Vol. 13 (9), pp. 2381-2389.e3. Date of Electronic Publication: 2025 Jul 17.
Publication Type: Journal Article; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-2201
DOI:10.1016/j.jaip.2025.06.018